The Prognostic Value of Thyroid-Stimulating Hormone in Patients with Coronary Artery Disease and Depression
- PMID: 35548588
- PMCID: PMC9081036
- DOI: 10.2147/IJGM.S364146
The Prognostic Value of Thyroid-Stimulating Hormone in Patients with Coronary Artery Disease and Depression
Abstract
Purpose: Patients with the comorbidity of coronary artery disease (CAD) and depression are very common and always have poor prognosis. The relationship between thyroid-stimulating hormone (TSH) levels and major cardiovascular event (MACE) in these patients is still unknown. We aimed to explore this association.
Patients and methods: We enrolled 203 CAD patients proven by coronary angiography (CAG). In the meanwhile, they were all assessed to have depression symptom by professional psycho-cardiologists. After an average follow-up of 23.7 months, patients were divided into two groups (high TSH group with TSH ≥ 1.395μIU/mL and low TSH group with TSH < 1.395μIU/mL) according to the cut-off value of baseline TSH. The impact of two different TSH groups for adverse events in CAD patients with depression was evaluated.
Results: The average age of these patients was 64.9 years old. The two TSH groups had no significant difference in the comparison of other baseline data. Area under the receiver operating characteristic (ROC) curves (AUC) analysis indicated the well-discriminatory power of TSH levels for the occurrence of MACE (AUC = 0.61, 95% CI: 0.52-0.70, P = 0.03). In the KM survival analysis, high TSH group had a higher risk of MACE (P = 0.029). After multi-factor adjustment, there still existed a higher risk of MACE in high TSH group (HR = 2.05, 95% CI: 1.08-3.88, P = 0.028).
Conclusion: In patients with the comorbidity of CAD and depression, higher TSH levels are associated with the occurrence of MACE. More researches need to be conducted to prove this association and explore whether the drug-related TSH reduction can decrease the occurrence of adverse events in the future.
Keywords: CAD; MACE; TSH; coronary artery disease; depression; thyroid-stimulating hormone.
© 2022 Li et al.
Conflict of interest statement
All the authors declare that they don’t have any conflict of interest in the study.
Figures



Similar articles
-
Effect of thyroid stimulating hormone on the prognosis of coronary heart disease.Front Endocrinol (Lausanne). 2025 Feb 17;16:1433106. doi: 10.3389/fendo.2025.1433106. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40034227 Free PMC article.
-
High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.Cardiovasc Diabetol. 2019 Dec 17;18(1):171. doi: 10.1186/s12933-019-0974-2. Cardiovasc Diabetol. 2019. PMID: 31847896 Free PMC article.
-
Association of platelet to lymphocyte ratio with in-hospital major adverse cardiovascular events and the severity of coronary artery disease assessed by the Gensini score in patients with acute myocardial infarction.Chin Med J (Engl). 2020 Feb 20;133(4):415-423. doi: 10.1097/CM9.0000000000000650. Chin Med J (Engl). 2020. PMID: 31977557 Free PMC article.
-
Age-related risk of major adverse cardiac event risk and coronary artery disease extent and severity by coronary CT angiography: results from 15 187 patients from the International Multisite CONFIRM Study.Eur Heart J Cardiovasc Imaging. 2014 May;15(5):586-94. doi: 10.1093/ehjci/jet132. Eur Heart J Cardiovasc Imaging. 2014. PMID: 24714312 Free PMC article.
-
Exploration of therapeutic models for psycho-cardiology: From cardiac to psychological rehabilitation.Heliyon. 2024 Mar 15;10(6):e27484. doi: 10.1016/j.heliyon.2024.e27484. eCollection 2024 Mar 30. Heliyon. 2024. PMID: 38524561 Free PMC article. Review.
Cited by
-
Effect of thyroid stimulating hormone on the prognosis of coronary heart disease.Front Endocrinol (Lausanne). 2025 Feb 17;16:1433106. doi: 10.3389/fendo.2025.1433106. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40034227 Free PMC article.
References
-
- Ren Y, Yang H, Browning C, et al. Prevalence of depression in coronary heart disease in China: a systematic review and meta-analysis. Chin Med J. 2014;127(16):2991–2998. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous